Related Experiment Video

Updated: Jun 6, 2026

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

Minimizing liver uptake of cationic Tc radiotracers with ether and crown ether functional groups

Young-Seung Kim1, Fan Wang, Shuang Liu

  • 1Young-Seung Kim, Shuang Liu, School of Health Sciences, Purdue University, 550 Stadium Mall Drive, West Lafayette, IN 47907, United States.

World Journal of Hepatology
|December 17, 2010
PubMed

Insights

New radiotracers are being developed to improve myocardial perfusion imaging for coronary artery disease (CAD). Research focuses on minimizing liver uptake for clearer heart imaging and earlier diagnosis in patients with suspected CAD.

Area of Science:

  • Nuclear Medicine
  • Radiochemistry
  • Cardiology

Background:

  • Coronary artery disease (CAD) is a leading cause of death globally.
  • Myocardial ischemia requires prompt detection to prevent irreversible damage, especially in the elderly.
  • Current myocardial perfusion imaging agents like (99m)Tc-Sestamibi and (99m)Tc-Tetrofosmin have limitations due to high liver uptake.

Purpose of the Study:

  • To review recent research on developing novel (99m)Tc radiotracers with reduced liver uptake for myocardial perfusion imaging.
  • To enhance the diagnostic accuracy of coronary artery disease assessment.
  • To improve imaging protocols for faster and higher quality cardiac scans.

Main Methods:

  • Investigating the use of ether and crown ether-containing chelators to modify cationic (99m)Tc radiotracers.
  • Evaluating strategies to minimize liver accumulation of radiotracers.
  • Assessing the impact of reduced liver uptake on heart-to-liver ratios and image quality.

Main Results:

  • Novel chelators show promise in reducing liver uptake of (99m)Tc radiotracers.
  • Faster liver clearance facilitates shorter imaging times (< 30 min post-injection).
  • Improved heart/liver ratios enhance the detection of coronary artery disease extent.

Conclusions:

  • Minimizing liver uptake in (99m)Tc radiotracers is crucial for improving myocardial perfusion imaging.
  • Development of new agents with ether/crown ether chelators offers a promising approach for better CAD diagnosis.
  • Optimized radiotracers can significantly benefit patients with suspected coronary artery disease.

Keywords:
Cationic 99mTc radiotracersMyocardial perfusion imagingSingle photon emission computed tomography

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method09:08

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

Related Concept Videos

Crown Ethers02:36

Crown Ethers

Crown ethers are cyclic polyethers that contain multiple oxygen atoms, usually arranged in a regular pattern. The first crown ether was synthesized by Charles Pederson while working at DuPont in 1967. For this work, Pedersen was co-awarded the 1987 Nobel Prize in Chemistry. Crown ethers are named using the formula x-crown-y, where x is the total number of atoms in the ring and y is the number of ether oxygen atoms. The term 'crown' refers to the crown-like shape that these ether molecules take.
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
Masking and Demasking Agents01:19

Masking and Demasking Agents

EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...